NCT00248209 - Female Orgasmic Disorder (FOD) and Wellbutrin XL | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Orgasmic Disorder

Interventions

DRUG

Wellbutrin XL

Patients randomized to the bupropion treatment group will receive bupropion XL150 mg in the AM for 7 days increasing to 300mg/day (single daily dose). The investigator can increase the dose to 450mg per day at Day 28 if clinically indicated.

Trial Locations (1)

44109

MetroHealth Medical Center, Cleveland